VA to offer new ketamine-based nasal spray to help combat depression – Task & Purpose

Editor’s Note: This article by Patricia Kime originally appeared on Military.com, a leading source of news for the military and veteran community. The newest FDA-approved medication to treat severe depression, a nasal spray based on the anesthetic (and misused hallucinogenic party drug) ketamine, will soon be available to veterans treated within the Department of Veterans Affairs. In a move that may help thousands of former service members with depression that has not improved with other treatments, VA officials announced Tuesday that the department’s doctors are now authorized to prescribe Spravato, the brand name for esketamine, a molecular variation of ketamine. ...

Gepostet in der Kategorie Lebensweise (Anzahl der ansichten:) 5

Ähnlich Nachrichten